URSY.NEWS / MIT Technology Review / 9 Oct 2026
We’re still figuring out the side effects of GLP-1 weight-loss drugs
Publisher access: Metered. This source-level label does not guarantee access to every article.
This week my colleague Antonio Regalado had an interesting update on GLP-1 weight-loss drugs. According to research presented at an aging meeting in Boston, these drugs seem to affect at least some measures of biological age. Overweight and diabetic people who take GLP-1s have a biological age around two to three years younger than similar…
Read the full story at www.technologyreview.com
URSY.NEWS archives headline details from the publisher's own feed and links you to the publisher. The article itself lives — and stays — with MIT Technology Review.
Time supplied by the publisher feed. First observed by URSY: